Impact of switching to injectables cabotegravir and rilpivirine on sleep disturbances in a cohort of people living with HIV.
Mazzitelli MariaElena AgostiniEleonora VaniaNicolò PresaLolita SassetDavide LeoniSamuele GardinVincenzo ScaglioneAnnamaria CattelanPublished in: HIV research & clinical practice (2024)
To the best of our knowledge, this is the first study exploring impact of switching to ICAB/RPV on SD. Despite integrase inhibitor have been associated with SD, we did not observed a negative impact on sleep quality after the switch to ICAB/RPV. More studies and with larger number of people are necessary to confirm our results.